3D-printed graft developed by researchers at Harvard’s Wyss Institute, Harvard SEAS, and Mass Eye and Ear to be commercialized by Desktop Health, following the startup’s acquisition
Create the future
Our team excels at convening extraordinary leaders who have the vision to bring transformative technologies to market.
In the past decade, Harvard’s research innovations have formed the basis of more than 145 new startup companies in Massachusetts and around the world. The 90+ startups we've launched in just the past 5 years have collectively raised more than $4.5 billion in equity financing.
New companies are taking shape all the time. Take a look at our Emerging Startups.
Harvard faculty are preeminent scholars and prolific inventors. In OTD, we also understand that some academic innovations need a boost to succeed commercially.
OTD’s pioneering technology accelerator programs—the Blavatnik Biomedical Accelerator and the Physical Sciences & Engineering Accelerator—help bridge the development gap, providing focused funding and resources to validate and de-risk promising technologies for successful partnering.
What ultimately makes it all work? Passionate people.
Our wide network of venture capitalists and entrepreneurs—many of whom are Harvard alumni—give generously of their time and expertise, leading and investing in new startup companies, engaging with labs as Entrepreneurs in Residence or Experts in Residence, serving on our accelerator advisory committees, speaking at OTD events, and making valuable connections throughout Cambridge and Boston.
Harvard licenses technology to Obatala Sciences to advance discovery in obesity, diabetes, and cancer
Development by New Orleans biotech company to enable studies of human fat tissue in vitro
Mass. startup Metalenz, Inc., to bring flat optics to consumer electronics and more